Role of vasodilators in regurgitant valve disease

Current Treatment Options in Cardiovascular Medicine

Volumn 8, Issue 6, 2006, Pages 428-434

  Evangelista, Artur ^a   Tornos, Pilar ^b   Sambola, Antonia ^b   Permayer Miralda, Gaieta ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FELODIPINE; HYDRALAZINE; LISINOPRIL; NIFEDIPINE; NITROPRUSSIDE SODIUM; PLACEBO; QUINAPRIL; VASODILATOR AGENT;

ACUTE DISEASE; AORTA VALVE REGURGITATION; CHRONIC DISEASE; CLINICAL TRIAL; COUGHING; DISEASE SEVERITY; DRUG INDICATION; ECHOCARDIOGRAPHY; FLUSHING; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART PALPITATION; HEART VALVE REGURGITATION; HEART VALVE SURGERY; HUMAN; HYPERTENSION; LONG TERM CARE; LUPUS LIKE SYNDROME; MITRAL VALVE REGURGITATION; PROGNOSIS; RANDOMIZATION; REVIEW; SIDE EFFECT; TREATMENT CONTRAINDICATION; VASCULAR RESISTANCE;

EID: 33751010174     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-006-0030-x     Document Type: Review

References (37)

1. Levine HJ, Gaasch WH: Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol 1996, 28:1083-1091.
2. Kim YJ, Jones M, Shiota T, et al.: Effect of load alterations of the effective regurgitant orifice area in chronic aortic regurgitation. Heart 2002, 88:397-400.
3. Reimold SC, Byrne JG, Caguioa ES: Load dependence of the effective regurgitant orifice area in a sheep model of aortic regurgitation. J Am Coll Cardiol 1991, 18:1085-1090.
4. Cooper HA, Gersh BJ: Treatment of chronic mitral regurgitation. Am Heart J 1998, 135:925-936.
5. Greenberg B, Massie B, Bristow JD, et al.: Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial. Circulation 1988, 78:92-103.
6. Lin M, Chiang H, Lin S, et al.: Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. J Am Coll Cardiol 1994, 24:1046-1053.
7. Banaszewski M, Rydlewska-Sadowska W, Rubkiewicz S: Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation. J Heart Valve Dis 1998, 7:488-499.
8. Schön HR, Dorn P, Barthel P, Schömig A: Effects of 12 months of quinapril therapy in asymptomatic patients with chronic aortic regurgitation. J Heart Valve Dis 1994, 3:500-509.
9. Sondergaard L, Aldershvile J, Hildebrandt P, et al.: Vasodilatation with felodipine in chronic asymptomatic aortic regurgitation. Am Heart J 2000, 139:667-674.
10. Wisenbaugh T, Sinovich V, Dullabh A, Sareli P: Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation. J Heart Valve Dis 1994, 3:197-204.
11. Scognamiglio F, Fasoli G, Ponchia A, Dalla-Volta S: Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 1990, 16:424-429.
12. Gaasch WH, Sundaram M, Meyer TE: Managing asymptomatic patients with chronic aortic regurgitation. Chest 1997, 111:1702-1709.
13. Novo S, Pinto A, Abrignani MG, et al.: Calcium channel blockers and peripheral arterial flow in normal and in hypertensive subjects. Am J Nephrol 1986, 6(suppl 1):87-90.
14. Evangelista A, Tornos P, Sambola A, et al.: Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 2005, 353:1342-1349.
15. Bolen JL, Alderman EL: Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation. Circulation 1976, 53:879-883.
16. Shen WF, Roubin GS, Hirasawa K, et al.: Noninvasive assessment of acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation. J Am Coll Cardiol 1984, 4:902-907.
17. Rothlisberger C, Sareli P, Wisenbaugh T: Comparison of single-dose nifedipine and captopril for chronic severe aortic regurgitation. Am J Gardiol 1993, 72:799-804.
18. Reske SN, Heck I, Kropp J, et al.: Captopril mediated decrease of aortic regurgitation. Br Heart J 1985, 54:415-419.
19. Scognamiglio R, Rahimtoola SH, Fasoli G, et al.: Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994, 331:689-694.
20. Gaasch WH, Schick EC: Symptoms and left ventricular size and function in patients with chronic aortic regurgitation. J Am Coll Cardiol 2003, 41:1325-1328.
21. Manyari DE, Yunus A: Nifedipine in severe aortic regurgitation. N Engl J Med 1995, 332:1302-1303.
22. Bonow RO, Carabello B, Chatterjee K, et al.: ACC/AHA 2006 Guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardol 2006, 48:e1-e148.
23. Yoran C, Yellin EL, Becker RM, et al.: Mechanism of reduction of mitral regurgitation with vasodilator therapy. Am J Cardiol 1979, 43:773-777.
24. Chatterjee K, Parmley WW, Swan HJ, et al.: Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvular apparatus. Circulation 1973, 48:684-690.
25. Weiland DS, Konstam MA, Salem DN, et al.: Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1986, 58:1046-1050.
26. Pfeffer MA, Braunwald E, Moye LA, et al.: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992, 327:669-677.
27. Evangelista-Masip A, Bruguera-Cortada J, Serrat-Serradell R, et al.: Influence of mitral regurgitation on the response to captopril therapy for congestive heart failure caused by idiopathic dilated cardiomyopathy. Am J Cardiol 1992, 69:373-376.
28. Greenberg BH, DeMots H, Murphy E, Rahimtoola SH: Arterial dilators in mitral regurgitation: effects on rest and exercise hemodynamics and long-term clinical follow-up. Circulation 1982, 65:181-187.
29. Wisenbaugh T, Sinovich V, Dullabh A, Sareli P: Six month pilot study of captopril on left ventricular performance in severe mitral regurgitation. Am J Cardiol 1992, 69:348-353.
30. Schön HF, Schröter G, Blömer H, Schöming A. Beneficial effects of a single dose of quinapril on left ventricular performance in chronic mitral regurgitation. Am J Cardiol 1994, 73:785-791.
31. Host U, Kelback H, Hildebrandt P, et al.: Effect of ramipril on mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol 1997, 80:655-658.
32. Tischler MD, Rowan M, LeWinter MM: Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol 1998, 82:242-245.
33. Dujardin KS, Sarano M, Bailey KR, et al.: Effect of losartan on degree of mitral regurgitation quantified by echocardiography. Am J Cardiol 2001, 87:570-576.
34. Perry GJ, Wei CC, Hankes GH, et al.: Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog. J Am Coll Cardiol 2002, 39:1374-1379.
35. Nemoto S, Hamawaki M, De Freitas G, Carabello BA: Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol 2002, 40:149-154.
36. Scognamiglio R, Negut Ch, Palisi M, et al.: Long-term and functional results after aortic valve replacement in asymptomatic patients with chronic severe aortic regurgitation and left ventricular dysfunction. J Am Coll Cardiol 2005, 45:1025-1030.
37. Plante E, Lachance D, Gaudreau M, et al.: Effectiveness of beta-blockade in experimental chronic aortic regurgitation. Circulation 2004, 110:1477-1483.